The U.S. stock market ended mixed on Friday as investors weighed escalating Middle East tensions and weakness in semiconductor stocks. The S&P 500 edged up 0.05% to 7,411.98, the Dow Jones Industrial Average gained 235.60 points (+0.46%) to 51,947.25, helped by a 3.5% rise in Apple, while the Nasdaq Composite fell 0.64% to 24,975.82. For the week, the S&P 500 lost 0.6%, the Nasdaq fell 2.1%, and the Dow slipped 0.4%, marking the Dow’s third consecutive weekly decline.
Investor sentiment remained cautious after reports that President Donald Trump is considering a larger military attack on Iran. Hopes of potential peace talks between the U.S. and Iran, reportedly being explored through Pakistan with China’s involvement, briefly lifted markets before concerns over possible military escalation resurfaced. Oil prices retreated from weekly highs, with Brent crude falling nearly 4% to US$96.78 per barrel after exceeding US$100 earlier in the week, while WTI crude declined 3% to US$89.31 per barrel.
President Donald Trump’s latest tariff policy is facing fresh legal uncertainty after the administration imposed Section 301 tariffs on imports from more than 80 countries, covering 99.4% of U.S. trade, on the grounds of combating forced labour. Critics argue the tariffs are an attempt to recreate the global tariff regime previously struck down by the U.S. Supreme Court under the International Emergency Economic Powers Act (IEEPA). A lawsuit has already been filed by two small businesses, with legal experts divided on whether the Section 301 tariffs can survive court scrutiny. While some believe the tariffs exceed the intended scope of Section 301, others say the law gives the administration broad discretion. Businesses are being advised to plan based on the current tariffs rather than expect a quick reversal.
Chipmakers were among the biggest drags despite generally solid earnings. Intel dropped nearly 8%, Micron fell 7%, AMD declined 3.3%, Broadcom lost 2.7%, and the VanEck Semiconductor ETF (SMH) fell 3% as investors rotated out of semiconductor stocks.
Second-quarter earnings season continued to outperform expectations. With 27% of S&P 500 companies having reported, 86% have beaten earnings estimates and 80% have exceeded revenue forecasts. FactSet now expects 37.9% year-on-year earnings growth for the quarter, up sharply from 23.2% projected at the end of June, potentially making it the strongest earnings growth since Q3 2021. Nine of the index’s eleven sectors have seen earnings estimates revised higher, while 11 companies have issued positive third-quarter guidance compared with nine negative outlooks.
Meanwhile, investor Michael Burry revealed he remains bearish on technology stocks, maintaining short positions in Tesla, Nvidia, the Invesco QQQ ETF, and Palantir. Tesla shares have fallen about 26% in July, including a 15% plunge after earnings and another 3% decline on Friday, leaving the stock around US$308. Burry said his original Tesla short was initiated at US$416.22.
Sector performance reflected the weakness in mega-cap technology stocks. Communication Services and Consumer Discretionary each fell about 6% for the week. Tesla suffered its worst weekly decline since March 2020, while Alphabet dropped 7.1% after earnings despite reporting 82% cloud revenue growth, as investors focused on its increased 2025 capital expenditure guidance of up to US$205 billion. Geopolitical developments and energy prices are expected to remain key factors influencing inflation expectations, bond yields and the Federal Reserve’s interest rate outlook.
Separately, Nvidia announced a strategic partnership with SK Hynix that could be worth up to US$500 billion over several years, securing supplies of high-bandwidth memory (HBM) for its next-generation AI chips and supporting large-scale AI data centres expected to come online in 2027. The project targets 2 gigawatts of computing capacity, implying hundreds of thousands of GPUs. Nvidia also committed US$1 billion to invest in Naver’s AI cloud infrastructure. Meanwhile, Samsung Electronics signed an estimated US$200 billion agreement with Broadcom to expand cooperation in memory and foundry technologies, highlighting continued massive investment in global AI infrastructure.
Samsung and SK Hynix: South Korea’s President Lee Jae Myung is expected to oversee the announcement of major AI-related agreements between Samsung Electronics, SK Hynix and leading US technology companies during his Silicon Valley visit. The deals are expected to include long-term memory chip supply agreements, strategic partnerships and investment memorandums. The visit follows South Korea’s US$880 billion AI and semiconductor investment plan, with over half of the planned 8GW first-phase AI data centre capacity expected to be converted into concrete projects. Around 80%–90% of the demand underpinning these investments comes from US technology companies. President Lee will also meet executives from Nvidia, OpenAI, Anthropic and Broadcom, and unveil the “San Francisco AI Declaration”, outlining South Korea’s ambition to become a leading AI infrastructure provider.
—————————————————————————————————————————————————
Morgan Stanley remains bullish on several stocks ahead of earnings. Alibaba remains a top pick despite a reduced price target of US$180 (from US$190), supported by its cloud leadership, AI growth, strong cash flow, dividends and share buybacks. Grab is expected to report 22% revenue growth and adjusted EBITDA of US$166 million for the second quarter, prompting Morgan Stanley to raise its price target to US$6.25 from US$5.90. The bank also reiterated an Overweight rating on Cadence Design Systems with a US$370 target price, citing Agentic AI and margin recovery, while increasing Natera’s target price to US$310 from US$250. Apple remains fundamentally strong, although Morgan Stanley expects a tougher near-term earnings setup due to its elevated valuation.
—————————————————————————————————————————————————
The rapid growth of GLP-1 weight-loss and diabetes drugs is driving a boom in healthcare logistics, prompting major logistics companies to invest heavily in temperature-controlled storage and transportation. Injectable GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound require strict cold-chain handling to maintain their effectiveness. UPS recently invested US$48 million in new temperature-controlled facilities, while the global market for temperature-sensitive biologics is expected to grow at a compound annual growth rate (CAGR) of 8.3% through 2033, reaching US$39.1 billion. Demand for GLP-1 drugs has surged, with 11% of Americans using them for weight loss in 2026, up from 3% in 2024.
Healthcare logistics has become a key growth engine for logistics firms. UPS recorded its first-ever US$3 billion healthcare revenue quarter in Q1 2026, driven by growing demand for biologics, cell and gene therapies. FedEx generated nearly US$10 billion in healthcare transportation revenue in fiscal 2026 and has established a dedicated life sciences business, leveraging AI, predictive tracking and its global air network to support increasingly complex pharmaceutical supply chains.
Other logistics providers are also expanding aggressively. C.H. Robinson surpassed US$1 billion in healthcare logistics revenue over the past year, citing strong GLP-1 demand, while DHL plans to invest €2 billion (US$2.25 billion) in healthcare logistics by 2030, with half allocated to the Americas. DHL is also using AI to monitor temperatures, expanding pharmaceutical warehousing services and operating dedicated pharmaceutical air corridors to ensure medicines are delivered on time and within strict temperature requirements.
Overall, the rapid growth of biologic medicines and GLP-1 therapies is transforming healthcare logistics into one of the fastest-growing and most attractive segments for global logistics companies, with cold-chain infrastructure, AI-powered monitoring and end-to-end supply chain visibility becoming key competitive advantages.
—————————————————————————————————————————————————
Singapore REIT managers are becoming more cautious on interest rates, with none expecting their average cost of debt to decline. The 3-month compounded SORA has rebounded to 1.15%, and some REIT managers are now forecasting higher funding costs. In the U.S., RHB notes that markets have increased expectations to around 1.8 Federal Reserve rate hikes by end-2026, up from 1.2 hikes just a week earlier. The upcoming FOMC meeting on July 28–29 is still expected to leave the Fed funds rate unchanged at 3.50%–3.75%.
Higher interest rate expectations and geopolitical tensions could strengthen the U.S. dollar and weigh on investor risk appetite, creating a less favourable environment for REITs. Nevertheless, buying interest remains in quality REITs such as CapitaLand Integrated Commercial Trust, Frasers Centrepoint Trust, ParkwayLife REIT, ESR-REIT and Centurion Accommodation REIT.
—————————————————————————————————————————————————
Zico Holdings has transformed itself from a regional law firm support provider into a diversified financial services platform under Group CEO Kelvin Ng, who has spent 30 years with the organisation. Ng sees significant growth in Islamic finance, positioning Singapore as a stable hub for Shariah-compliant financial services. Rather than maintaining a presence in all 10 ASEAN countries, Zico is concentrating on high-growth markets such as Indonesia, Thailand and Vietnam, which together represent around 450 million people, with Vietnam’s 100 million population offering strong long-term potential.
